When was InpharmD founded?

InpharmD was founded in 2014 and raised its 1st funding round 7 years after it was founded.

Where is InpharmD located?

InpharmD is headquartered in Atlanta, United States.

How many employees does InpharmD have?

As of Aug 31, 2026, the latest employee count at InpharmD is 40.

Is InpharmD a funded company?

InpharmD is a funded company, having raised a total of $6.62M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2021.

How much is InpharmD worth?

The latest valuation of InpharmD is $***** as of Jan 01, 2021.

When was the latest funding round of InpharmD?

InpharmD's latest funding was a $***** Seed round on Dec 07, 2023, with participation from 4 investors.

Where does InpharmD rank among its competitors?

InpharmD ranks 12th amongst 65 active competitors, of which 9 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was BAMF Health, which secured $59.7M in May, 2026.

Who are the top competitors of InpharmD?

InpharmD's top competitors include Fullscript, BAMF Health and Omega Therapeutics. Among them, BAMF Health secured the most recent funding round in May, 2026.

InpharmD - 2026 Company Profile, Funding & Competitors

InpharmD is a seed company based in Atlanta (United States), founded in 2014. It operates as an Online medical assistant for providers decision support system. InpharmD has raised $6.62M in funding from Y Combinator and 645 Ventures, with a current valuation of $*****. The company has 65 active competitors, including 9 funded and 6 that have exited. Its top competitors include companies like Fullscript, BAMF Health and Omega Therapeutics.

Company Details

InpharmD is a medical assistant for providers' decision support system. The company has developed digital medication information and literature searching tool for healthcare providers. The stakeholders can enter a health-related question via a website or app and receive a customized, evidence-based response within a time period requested. The drug information inquiries are answered with a summary of appropriate evidence from an inbuilt database.

Website: inpharmd.com/our_story
Social

Key Metrics

Founded Year

2014

Location

Atlanta, United States

Stage

Seed

Total Funding

$6.62M in 2 rounds

Latest Funding Round

Seed, Dec 07, 2023, $*****

Post Money Valuation

$***** as on Jan 01, 2021

Investors

Y Combinator & 5 more

Ranked

12^th among 65 active competitors

Employee Count

40 as on Aug 31, 2026

Similar Companies

Fullscript & 87 more

View InpharmD's full profile

InpharmD has raised a total funding of $6.62M over 2 rounds. Its first funding round was on 2021. Its latest funding round was a Seed round on Dec 07, 2023 for $*****. 4 investors participated in its latest round. InpharmD has 6 institutional investors.

Here is the list of recent funding rounds of InpharmD:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 07, 2023	3946786	Seed	2143711	7206998	7471319	3218265
2021	3361	Seed	6208	1563	Y Combinator	7260

Access funding benchmarks and valuations. Sign up today!

View details of InpharmD's funding rounds and investors

InpharmD's employee count trend

InpharmD has 40 employees as of Aug 26. Here is InpharmD's employee count trend over the years:

Uncover InpharmD's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of InpharmD include Fullscript, BAMF Health and Omega Therapeutics. Here is the list of Top 10 competitors of InpharmD, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Fullscript 1995, Ottawa (Canada), Series B	Provider of a supplements dispensing platform for health practitioners	$267M	Kayne Anderson Capital Advisors, Leonard Green and Partners ... & 9 others	69/100
2nd	BAMF Health 2018, Grand Rapids (United States), Series C	Developer of AI-enabled molecular imaging and theranostics	$63.7M	New Community Transformation Fund, Corewell Health Ventures ... & 1 others	55/100
3rd	Omega Therapeutics 2016, Cambridge (United States), Public	Provider of platform for human genome study for precision medicine	$211M	Flagship Pioneering, Fidelity Investments ... & 9 others	50/100
4th	Coriell Life Sciences 2013, Camden (United States), Acquired	Provider of precision medicine tools for clinicians	$10.1M	-	49/100
5th	Ardigen 2015, Krakow (Poland), Funding Raised	Provider of AI-driven solutions for drug discovery and clinical development	-	NCBR	44/100
6th	Aranscia 2022, Houston (United States), Unfunded	Provider of human-first diagnostic solutions for clinical professionals and diagnostic labs	-	-	43/100
7th	dātma 2016, Beaverton (United States), Seed	Provider of software to clinics for decision-making and omics data automation	$2.5M	Generator Ventures, National Science Foundation	42/100
8th	LifeOmic 2016, Indianapolis (United States), Acquired	Storage, management and analysis of omic data for health applications	-	-	39/100
9th	WellPro 2023, Atlanta (United States), Funding Raised	AI-powered decision support platform for functional & integrative medicine practitioners	-	MarketCap Investments™	38/100
10th	Decode Health 2013, Nashville (United States), Funding Raised	Precision medicine analytics platform for pharmaceutical, diagnostic, and technology companies	-	-	35/100
12th	InpharmD 2014, Atlanta (United States), Seed	Online medical assistant for providers decision support system	$6.62M	645 Ventures, Y Combinator & 4 others	32/100